Command Palette

Search for a command to run...

Clinical Trials · NCT06616961

Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus

Not Yet RecruitingPhase 3Semaglutide (Investigational)
Phase
Phase 3
Recruitment status
Not Yet Recruiting
Sponsor
Popular Medical College Hospital
Enrollment
480
Start date
Nov 2024
Locations
1 site, Bangladesh
Primary endpoint
Body Weight (kg)
View Semaglutide compound reference